Last reviewed · How we verify

NCT03659877

Identifying Physical Activity Intensity Through Accelerometry in Heart Failure

Completed NA Last updated 30 October 2018
What this trial tests

NA trial testing Physical activity in Heart Failure in 22 participants. Completed in 23 October 2018.

Timeline
3 April 2018
Primary endpoint
23 October 2018
23 October 2018

Quick facts

Lead sponsorUniversity of Exeter
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment22
Start date3 April 2018
Primary completion23 October 2018
Estimated completion23 October 2018
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Exeter

Who can join

18 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to identify and evaluate the range of values provided by accelerometers during a variety of typical daily lifestyle activities for heart failure patients, and to relate these to the measured intensity of performing each activity in the heart failure population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Physical activity assessment by accelerometry in people with heart failure.
    Dibben GO, Gandhi MM, Taylor RS, Dalal HM, et al · · 2020 · cited 21× · PMID 32817798 · DOI 10.1186/s13102-020-00196-7

Verify or expand the search:

Other trials of Physical activity

Trials testing the same drug.

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

Other University of Exeter trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03659877.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing